Electromed (ELMD) vs Standard BioTools (LAB)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Electromed (ELMD) has outperformed Standard BioTools (LAB) over the past year, gaining 14.4% versus a loss of 47.8%. Over five years, ELMD leads with a +156.6% price change compared with -87.3% for LAB. Standard BioTools is the larger company by market cap ($266.4 million vs $233.7 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ELMD | LAB |
|---|---|---|
| Share price | $28.20 | $0.6787 |
| Market cap | $233.70M | $266.44M |
| 1-day change | -0.25% | -6.00% |
| YTD return | -3.16% | -46.98% |
| 1-year return | +14.45% | -47.79% |
| 5-year return | +156.60% | -87.29% |
| P/E ratio (TTM) | 21.69 | — |
| Forward P/E | 46.23 | — |
| EPS (TTM) | $1.30 | $-0.12 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $47.40 | $1.72 |
| 52-week low | $23.01 | $0.63 |
| Distance from 52-week high | -40.51% | -60.54% |
| Analyst consensus | none | none |
| Avg. price target upside | +71.99% | +98.91% |
| Average volume | 105.23K | 1.57M |
| Shares outstanding | 8.29M | 392.58M |
| Employees | 195 | 385 |
| Sector | Healthcare | Healthcare |
| Industry | Medical Devices | Medical Devices |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- ELMD has outperformed LAB by 62.2 percentage points over the past year.
About Electromed
ELMD stock →Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients in the United States and internationally.
Healthcare · Medical Devices · 195 employees
About Standard BioTools
LAB stock →Standard BioTools Inc., together with its subsidiaries, develops, manufactures, and sells a range of instrumentation, consumables, and services to scientists and biomedical researchers to develop therapeutics in the Americas, Europe, the Middle East, Africa, and the Asia pacific. The company operates through Proteomics and Genomics segments.
Healthcare · Medical Devices · 385 employees
ELMD vs LAB FAQ
Which is bigger, Electromed or Standard BioTools?
Standard BioTools (LAB) is larger, with a market capitalization of $266.44M compared with $233.70M for Electromed (ELMD).
Which stock has performed better over the past year, ELMD or LAB?
ELMD returned +14.45% over the past 12 months, compared with -47.79% for LAB (price return, excluding dividends). Past performance does not predict future results.
Are Electromed and Standard BioTools in the same industry?
Yes. Both are classified in the Medical Devices industry within the Healthcare sector.